Nöroloji Polikliniğine Başvuran Hastalarda Korona Virus Hastaliği-19 İlişkili Korku ve Anksiyetenin Değerlendirilmesi

Öz

SARS-CoV-2, hızla yayıldı ve halk sağlığı için tehdit oluşturdu. İnsanların çoğu pandemiden psikolojik, sosyal ve ekonomik olarak etkilendi. Bu çalışmada, kronik nörolojik hastalığı olan hastalarda Koronavirüs 19 hastalığı (COVID-19) ilişkili anksiyete ve korku seviyesini araştırmayı amaçladık. Pandemi öncesinde polikliniğimizde takipte olan, kronik nörolojik hastalığı olan hastaları değerlendirdik. Demografik bilgiler, sosyal media kullanım bilgisi, pandemide hastaneye başvurularındaki değişim ve kendisinin ya da ailesinin COVID-19 geçirip geçirmedikleri kaydedildi. COVID-19 korku ve anksiyetesi; COVID-19 korku ölçeği (FC-19 S), Koronavirisanksiyete ölçeği (CAS) ile araştırıldı. Çalışma popülasyonu 247 hastadan (158 kadın, 89 erkek) oluşmaktadır. Hasta gruplarının dağılımı; %28,34 migren, % 12,5 inme, % 5,6 Parkinson hastalığı, % 34,8 Multipl sclerosis, % 13,36 epilepsi, %5,26 diğer şekildeydi. Ortalama FC-19 S, CAS skorları sırasıyla 18±6,76 ve 1,31±2,42 idi. Grupların FC-19 S and CAS skorları arasında anlamlı fark saptanmadı (p>0.05) fakat kadınların FC-19 S skorları yüksekti (p=0,001). Sosyal media kullanım oranı % 67,6’ ydi ve hastaların % 45,67’ si COVID-19 ilişkili haberlerden etkilendiklerini belirttiler. Kronik hastalığı olanların sağlık profesyonelleriyle yeterli sıklıkta iletişim kurması hastaların ilaç uyumu ve izlem kontrolleri için anahtardır. Pandemi döneminde sağlık sisteminin yeniç özümlere ihtiyacı vardır. Ülkemizde teletıp, video konsültasyon gibi teknolojik araçların kullanımına ilişkin gerekli yasal düzenlemelerin tamamlanması gerektiğini düşünüyoruz.

Anahtar Kelimeler

• kronik nörolojik hastalık
• pandemi
• koronavirüs
• korku
• anksiyete

Evaluation of Corona Virus Disease-19 Related Fear and Anxiety in Patients Admitted to Neurology Outpatient Clinic

Öz

SARS-CoV-2, quickly spread and became a threat to public health. The majority of the people are affected psychologically, socially, economically by the pandemic. We aimed to investigate the level of anxiety and fear about coronavirus disease 19 (COVID-19) and related factors in patients with chronic neurological disease We evaluated the patients with chronic neurological disease who have been followed up at our outpatient clinic before the pandemic. Demographical data, information about social media use, change of hospital admission during the pandemic and status of the patients' or family members' whether they had the COVID-19 disease were recorded. We investigated the fear of COVID-19 and coronavirus anxiety of the study population with Fear of COVID-19 and The Coronavirus Anxiety Scale. The study population was consisted of 247 patients (158 women, 89 men). The distribution of the patient groups was as follow: 28.34 % headache, 12.5 % stroke, 5.6% Parkinson's disease, multiple sclerosis 34.8%, epilepsy 13.36%, others 5.26%. Mean scores of FC-19 S, CAS of the study group were 18±6.76 and 1.31±2.42, respectively. There was no statically significant difference in the FC-19 S and CAS scores between chronic neurological disease groups (p>0.05) but females reported higher FC-19 S scores (p= 0.001). Rate of social media users was 67.6 % and 45.67 % of the patients reported that they were affected by the COVID-19 related news. Often enough, communication with chronic disease patients by healthcare professionals is a key to the patients to be adherence to the medications and follow up visits. During the pandemic, the health system needs new solutions. We think that legal regulations regarding using technological tools such as telemedicine and video consultancy should be completed in our country.

Anahtar Kelimeler

• chronic neurologic disease
• pandemic
• coronavirus
• fear
• anxiety

Kaynakça

1. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y I, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lance 2020; 395(10223): 497–506.
2. WHO (2020). Coronavirus disease (COVID-19) outbreak. https://www.who.int/dg/speec hes/detai l/who-direc tor-generals-opening-remarks-at-the-media -brief ing-on-covid -19, accessed 11 March 2020.
3. Ministry of Health of Turkish Republic (2020). Turkey daily coronavirus table. https://covid 19.saglik.gov.tr/ accessed 13 April 2020.
4. Arpaci I, Karatas K, Baloglu M. The development and initial tests for the psychometric properties of the COVID-19 Phobia Scale (C19P-S). Pers Individ Dif 2020;164(1):164:110108. doi: 10.1016/j.paid.2020.110108. Epub 2020 May 11.
5. Zandifar A, Badrfam R. Iranian mental health during the COVID-19 epidemic. Asian Journal of Psychiatry; 51: 101990. https://doi.org/10.1016/j.ajp.2020.
6. https://covid19.saglik.gov.tr/TR-66393/covid-19-salgin-yonetimi-ve-calisma-rehberi.html 22mart 2021
7. Gazeteci Tekin H, Karaoglu P. Effects of COVID-19 Pandemic on Childhood Epilepsy Management; A Survey Study. Osmangazi Tıp Dergisi;43(4):318-323.
8. Romagnolo A, Balestrino R, Imbalzano G, Ciccone G, Riccardini F, Artusi CA, et al. Neurological comorbidity and severity of COVID-19. J Neurol. 2021;268(3):762-769.

9. Roca F, Lang PO, Chassagne P. Chronic neurological disorders and related comorbidities: role of age-associated physiological changes. Handb Clin Neurol2019; 167:105–122.
10. Bhaskar S, Bradley S, Israeli-Korn S, Menon B, Chattu VK, Thomas P, et al. Chronic Neurology in COVID-19 Era: Clinical Considerations and Recommendations From the REPROGRAM Consortium. Front Neurol 2020;11:664. doi: 10.3389/fneur.2020.00664
11. Ahorsu DK, Lin C, Imani V, Saffari M, Griffiths MD, Pakpour A H. The fear of COVID-19 scale: Development and initial validation. International Journal of Mental Health and Addiction 2020; https://doi.org/10.1007/s11469-020-00270-8
12. Lin C Y. Social reaction toward the 2019 novel coronavirus (COVID-19). Social Health and Behavior 2020; 3(1):1–2.
13. Bakioglu F, Korkmaz O, Ercan H. Fear of COVID-19 and positivity: Mediating role of intolerance of uncertainty, depression, anxiety, and stress. International Journal of Mental Health and Addiction 2020. https://doi.org/10.1007/s11469-020-00331-y
14. Satici B, Gocet Tekin E, Deniz M E, Satici SA. Adaptation of the Fear of COVID-19 Scale: Its association with psychological distress and life satisfaction in Turkey. International Journal of Mental Health and Addiction 2020. https://doi.org/10.1007/s11469-020-00294-0
15. Lee SA. Coronavirus Anxiety Scale: A brief mental health screener for COVID-19 related anxiety. Death Studies 2020;44(7): 393–401.
16. Evren C, Evren B, Dalbudak E, Topcu M, Kutlu N. Measuring anxiety related to COVID-19: A Turkish validation study of the CoronavirusAnxiety Scale. Death Studies 2020. https://doi.org/ 10.1080/07481187.2020.1774969
17. Bicer İ, Cakmak C, Demir H, Kurt M. Koronavirüs Anksiyete Ölçeği Kısa Formu: Türkçe Geçerlik ve Güvenirlik Çalışması. Anatolian Clinic the Journal of Medical Sciences (COVID 19 Özel Sayısı) 2020;25(1): 216-225 .
18. Sayık D, Yigit D, Acıkgöz A, Colak E, Mumcu O. Turkish Validity and Reliability of the Coronavirus Anxiety Scale. Eskisehir Med J 2021;2(1):16-22
19. Serafini G, Parmigiani B, Amerio A, Aguglia A, Sher L, Amore M, 2020. The psychological impact of COVID-19 on the mental health in the general population. QJM: An International Journal of Medicine 2020; 113(8): 531–537.
20. Limcaoco RSG, Mateos EM, Fernandez JM, Roncero C. Anxiety, worry and perceived stress in the world due to the COVID-19 pandemic, Preliminary Results. medRxiv 2020. https://doi.org/10.1101/2020.04.03.20043992
21. Qiu J, Shen B, Zhao M, Wang Z, Xie B, Xu Y. A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: implications and policy recommendations. Gen. Psychiatry2020; 33: e100213. https://doi.org/10.1136/gpsych-2020-100213
22. Sakib N, Bhuiyan AKMI, Hossain S, Al Mamun F, Hosen I, et al. Psychometric Validation of the Bangla Fear of COVID-19 Scale: Confirmatory Factor Analysis and Rasch Analysis. Int J Ment Health Addict. 2020;11:1-12.
23. Balsamo M & Carlucci L. Italians on the age of COVID-19:The self-reported depressive symptoms through web-based survey. Frontiers in Psychology 2020;(11):569276. https://doi.org/10.3389/fpsyg.2020.569276.
24. International Federation of Red Cross and Red Crescent Societies (IFRC). (2020). Mental health and psychosocial support for staff, volunteers and communities in an outbreak of novel coronavirus. https://pscentre.org/wp-content/uploads/2020/02/MHPSS-in-nCoV-2020_ENG-1.pdf (accessed 29 May 2020).
25. Beiske A, Svensson E, Sandanger I, Czujko B, Pedersen E, Aarseth J, et al. Depression and anxiety amongst multiple sclerosis patients. European journal of neurology 2008;15(3): 239–245.
26. Marrie RA, Reingold S, Cohen J, Stuve O, Trojano M, Sorensen PS, et al. The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review. Multiple sclerosis (Houndmills, Basingstoke, England) 2015; 21(3): 305–317
27. Public Health England. Guidance on social distancing for everyone in the UK. (2020). Available online at: https://www.gov.uk/government/publications/covid-19-guidance-on-social-distancing-and-for-vulnerable-people/guidance-on-social-distancing-for-everyone-in-the-uk-and-protectingolder-people-and-vulnerable-adults(accesed April5,2020)
28. PellinoG, Spinelli A. How COVID-19 outbreak is impacting colorectal cancer patients in Italy: a long shadow beyond infection. Dis. Colon Rectum 2020. https://doi.org/10.1097/DCR.0000000000001685. https://www.titck.gov.tr/duyuru
29. Hosgor H, Akozlu Z, Gunduz D. The perception concerning the COVID-19 pandemic: case of Turkey . The European Research Journal 2021;7(2):116-126
30. Depoux A, Martin S, Karafillakis E, Preet R, Wilder-Smith A, Larson H. The pandemic of social media panic travels faster than the COVID-19 outbreak. J Travel Med 2020; 27(3):taaa031. doi: 10.1093/jtm/taaa031.
31. Özkoçak V, Kırık AM. Social media and new coronavirus (Covid-19) pandemia in the context of the new world order. J Soc Sci 2020;45:133-54. [Article in Turkish]